Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improving immune–vascular crosstalk for cancer immunotherapy
Yuhui Huang, Betty Y.S. Kim, Charles K. F. Chan, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 3, pp. 195-203
Open Access | Times Cited: 441

Showing 26-50 of 441 citing articles:

Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-Analysis
Lihui Liu, Hua Bai, Chao Wang, et al.
Journal of Thoracic Oncology (2021) Vol. 16, Iss. 7, pp. 1099-1117
Open Access | Times Cited: 108
Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review
Cunqing Kong, Xingcai Chen
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 6427-6446
Open Access | Times Cited: 94
Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches
Nehad M. Ayoub, Sara K. Jaradat, Kamal M. Al-Shami, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 88
Transforming “cold” tumors into “hot” ones via tumor-microenvironment-responsive siRNA micelleplexes for enhanced immunotherapy
Yunfei Yi, Mian Yu, Chan Feng, et al.
Matter (2022) Vol. 5, Iss. 7, pp. 2285-2305
Open Access | Times Cited: 88
A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma
Wu‐tong Ju, Ronghui Xia, Dongwang Zhu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 76
Localization, tissue biology and T cell state — implications for cancer immunotherapy
Jason M. Schenkel, Kristen E. Pauken
Nature reviews. Immunology (2023) Vol. 23, Iss. 12, pp. 807-823
Open Access | Times Cited: 66
PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy
Duo Zhang, Albert M. Li, Guanghui Hu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 3, pp. 517-534.e8
Closed Access | Times Cited: 64
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 64
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy
Lihong Wang-Bishop, Blaise R. Kimmel, Verra M. Ngwa, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 56
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
Feng Wang, Ying Jin, Min Wang, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 1035-1043
Closed Access | Times Cited: 56
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 49
Adoptive cell therapy for cancer treatment
Shi Du, Jinyue Yan, Yonger Xue, et al.
Exploration (2023) Vol. 3, Iss. 4
Open Access | Times Cited: 47
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44
Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors
T. R. Chen, Mingzhao Wang, Yanchao Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 37
Tertiary lymphoid structures in anticancer immunity
Jean‐Luc Teillaud, Ana Houel, Marylou Panouillot, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 9, pp. 629-646
Closed Access | Times Cited: 35
TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer
Hongwei Lv, Qianni Zong, Cian Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 31
Microfluidic high-throughput 3D cell culture
Jihoon Ko, Dohyun Park, Jungseub Lee, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 6, pp. 453-469
Closed Access | Times Cited: 22
Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy
Yuting Wu, Xi Pu, Xu Wang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors
Peng Ouyang, Lijuan Wang, Jianlong Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells
Tengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, et al.
Cell stem cell (2024) Vol. 31, Iss. 7, pp. 989-1002.e9
Open Access | Times Cited: 17
Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer
Lydia Meder, Philipp Schuldt, Martin Thelen, et al.
Cancer Research (2018) Vol. 78, Iss. 15, pp. 4270-4281
Open Access | Times Cited: 145
Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy
Zecong Xiao, Zhenwei Su, Shisong Han, et al.
Science Advances (2020) Vol. 6, Iss. 6
Open Access | Times Cited: 130
The Reciprocity between Radiotherapy and Cancer Immunotherapy
Yifan Wang, Zhi-Gang Liu, Hengfeng Yuan, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 6, pp. 1709-1717
Open Access | Times Cited: 129
Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade
Qian Li, Yifan Wang, Weijuan Jia, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 7, pp. 1712-1724
Open Access | Times Cited: 117
Myeloid Cells in Glioblastoma Microenvironment
Alessandra De Leo, Alessio Ugolini, Filippo Veglia
Cells (2020) Vol. 10, Iss. 1, pp. 18-18
Open Access | Times Cited: 115

Scroll to top